Revenue: The sum of all revenue fields included for a company's operating activities.
Salarius Pharmaceuticals, Inc. (SLRX) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-1.71M |
|
-- |
|
-- |
|
$1.72M |
|
$-1.72M |
|
$0.01M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.72M |
|
$-1.72M |
|
1.66M |
|
1.66M |
|
$-1.03 |
|
$-1.03 |
|
| Balance Sheet Financials | |
$2.31M |
|
-- |
|
$0.03M |
|
$2.34M |
|
$2.28M |
|
-- |
|
-- |
|
$2.28M |
|
$0.06M |
|
$0.06M |
|
$0.06M |
|
2.08M |
|
| Cash Flow Statement Financials | |
$-1.18M |
|
-- |
|
$0.55M |
|
$2.43M |
|
$1.80M |
|
$-0.64M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
-- |
|
1.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2763.25% |
|
-2763.28% |
|
-73.08% |
|
-2763.28% |
|
$0.03 |
|
$-0.71 |
|
$-0.71 |
|